¡@¡@·|¡@¡@°T
Á`´Á¼Æ¡G²Ä491´Á 2009¦~²Ä43´Á (98.11.13µo¦æ) ¡i¥»´Á·|°T¤U¸ü¡j
¤½·|µo¤å
98.11.9 ¤K¤j¤½¨ó·|Áp¦X¦æ¤å ¥»¤½·|µo¤å¡]98¡^¥þ°ê¦èÃÄ¥N¶¯¦r²Ä209¸¹
¨ü¤åªÌ¡G¤¤¥¡°·±d«OÀI§½
¥D¦®¡G¶Q§½ÀÀ©ó98¦~11¤ë18¤é¤W¤È10ÂI¥l¶}¡u¬ãij¥þ¥Á°·±d«OÀIÃÄ«~¶O¥ÎÁ`ÃB¹ê¬I¤è®×¡v°Q½×·|¡A°ß¸Ó·|ij®É¶¡«ê»P¥Á¶¡°·«OºÊ·þÁp·ù©Ò¥l¶}¤§¡u¥ÎÃÄ¥h»Ùê¤Æ¡v®y½Í·|¤Î¬ã°Q·|®É¶¡¬Û¦P¡A«Ø½Ð ¶Q§½¼È©µ¨Ã¥t¦æ¾Ü´Á¥l¶}«ez·|ij¡A½Ð ¬d·Ó¡C
»¡©ú¡G
¤@¡B ¥Á¶¡°·«OºÊ·þÁp·ù©ó98¦~10¤ë22¤é¤½§i±N©ó98¦~11¤ë18¤é¤W¤ÈÁ|¿ì¡u¥ÎÃÄ¥h»Ùê¤Æ-½ÍÃÄ«~¬Fµ¦¡B¥ÎÃĦw¥þ»P¥Á²³¥ÎÃÄÅv¯q¡vÂù¦V®y½Í·|¤Î¬ã°Q·|¡A¦Ó ¶Q§½¥ç11¤ë4¤é¨çª¾¦U¤½¨ó·|±N©ó¦P¤é¤W¤È10ÂI¥l¶}¡u¬ãij¥þ¥Á°·±d«OÀIÃÄ«~¶O¥ÎÁ`ÃB¹ê¬I¤è®×¡v°Q½×·|¡C
¤G¡B ¦³Å²©ó¦¹¤G·|ij°Q½×ijÃD§¡¹ï¼t°ÓÅv¯q¼vÅT¬Æ¹d¡A«Ø½Ð ¶Q§½¼È©µ¸Ó¡u¬ãij¥þ¥Á°·±d«OÀIÃÄ«~¶O¥ÎÁ`ÃB¹ê¬I¤è®×¡v°Q½×·|®É¶¡¨Ã¥t¾Ü´Á¥l¶}¡A¤£³Ó·P¿E¡C
¤½·|¦¬¤å
¥x¥_¥«¥ßÁp¦XÂå°|
98.11.9¥_¥«ÂåÁ`¦r²Ä09834359700¸¹ ¨ç ¥»¤½·|¦¬¤å555¸¹¡]11¤ë¡^
¥D¦®¡G¶Q¤½¥q©ÓÅó¥»°|¡u98.99¦~¦èÃÄÃÄ«~±ÄÁÊ¡v¡]®×¸¹¡GB9801¡^±ÄÁÊ¡A«´¬ù»ùª÷½Õ¾ã¬ÛÃö¨Æ©y¡A´_¦p»¡©ú¡A½Ð ¬d·Ó¡C
¬dÅçµn°O»Pªk³W¬ÛÃö°T®§
¡Î¥»´Á·s¼W
1. 98¦~11¤ë17¤é¡]¬P´Á¤G¡^13;30-17:00¡FÃĬF³B©e°U¥xùÖ¸ê°T¬ì§Þ©ó¥x¤j¶°«ä·|ij¤¤¤ß-Ĭ®æ©Ô©³ÆU¡]¥x¥_¥«Ã¹´µºÖ¸ô4¬q85¸¹¡^Á|¦æ¡yÃÄ«~¬dÅçµn°O¼f¬d§@·~¹q¤l¤ÆÀ³¥Î±À¼s»¡©ú·|¡z¡A½Ð¤Whttp://www.pharmasoftware.net/c/c.html¶i¦æ½u¤W³ø¦W¡C
2. 98¦~11¤ë17¤é¡]¥_°Ï¡^¡B19¤é¡]¤¤°Ï¡^¡B20¤é¡]«n°Ï¡^¡AÃÄÀ˧½©e°U¥xÆWÃĪ««~½è¨ó·|¡]TPQRI¡^Á|¿ì98¦~¡uPIC/S GMP½×¾Â¡vÁ¿®y¡A§K¶O¡A11/10³ø¦WºI¤î¡A¦WÃB¦³¡A½Ð¾¨¦¤Wºô³ø¦W¡Ghttp://www.tpqri.org.tw ¡C
3. 98¦~11¤ë18¤é¡]¬P´Á¤T¡^14:00-17:00¡F°]¹Îªk¤HÃÄ®`±ÏÀÙ°òª÷·|©ó¤¤°êÂåÃĤj¾Çªþ³]Âå°|Àù¯g¤¤¤ß¤j¼Ó¤@¼Ó¶¥±è±Ð«Ç¡]¥x¤¤¥«¾Ç¤h¸ô6¸¹¡^¼W¿ì¥x¤¤³õ¦¸¡u98¦~«×ÃÄ«~¦w¥þºÊµø»PÃÄ«~¤£¨}«~³q³ø¨t²Îº[¦^¦¬§@·~¤§¼t°Ó±Ð¨|°V½m«Å¾É·|¡v¡C½Ðµù©ú°Ñ¥[¤Hû©m¦W¡B©ÒÄݤ½¥q¡BÁpµ¸¹q¸Ü¤Î¹q¤l¶l¥ó«H½c e-mail¦Ü recall@tdrf.org.tw¶i¦æ³ø¦W¡C
¡Î4. 98¦~11¤ë18¤é¡]¬P´Á¤T¡^8:30-17:00¡F¥Á¶¡ºÊ·þ°·«OÁp·ù©ó¥x¤j¤½½Ã¾Ç°|¤G¼Ó¡]201¡^°ê»ÚºtÁ¿ÆU¡]¥x¥_¥«®}¦{¸ô17¸¹2¼Ó¡^Á|¿ì¡y¥ÎÃÄ¥h»Ùê¤Æ¡z--½ÍÃÄ«~¬Fµ¦¡B¥ÎÃĦw¥þ»P¥Á²³¥ÎÃÄÅv¯qÂù¦V®y½Í·|º[¬ã°Q·|¡C§K¶O¡Aºô¸ô³ø¦W½Ð¦Ü http://mice.tw-npo.org/act_detail.php?act_serial=20091022004247ÂI¡u§Ún³ø¦W¡v§Y¥iµn¿ý³ø¦Wµe±¡C
5. 98¦~11¤ë19¤é¡]¬P´Á¥|¡^8:30-17:00¡F°]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß°²±iºaµo°òª÷·|°ê»Ú·|ij¤¤¤ß1001«Ç¡]¥x¥_¥«¤¤¤s«n¸ô11¸¹10¼Ó¡^Á|¿ì¡y2009¦~²ÓMªvÀø¬ã°Q·| - ªk³W¬ì¾Ç¡B¤HÅé¸ÕÅç®×¨Ò¤À¨É»P²£·~¤Æµ¦²¤¡C¬ã°Q·|¥Ø¼Ð¬°¡G¡]1¡^¨Ï»P·|ªÌ¤F¸Ñ²{¦æ²ÓMªvÀø²£«~Á{§É«eµû¦ônÂI¡B¡]2¡^´£¨Ñ»P·|ªÌ²ÓMªvÀø¦¨¥\®×¨Ò¤§¸gÅç¤À¨É¡B¡]3¡^´£¨Ñ»P·|ªÌ²ÓMªvÀø²£·~¤Æµ¦²¤¤§°Q½×¡C¡z§K¶O¡A·q½Ð¤Î¦ºô¸ô³ø¦W¡Chttp://cde.org.tw¡C
6. 98¦~11¤ë19¤é¡]¬P´Á¥|¡^9:00-17:30¡F¸gÀÙ³¡¤u·~§½§Þ³Nµo®i¤¤¤ß©ó¥x¤j¶°«ä·|ij¤¤¤ß¬¥§JÆU¡]¥x¥_¥«Ã¹´µºÖ¸ô4¬q85¸¹B1¡^Á|¿ì¡u¬ü°ê±M§Qªk³Ì·sµo®i¤Î¹ï¥Í§ÞÂåÃļvÅT¤§¹ê°È¤ÀªR¡v¶O¥Î2,500¤¸
¡Î7. 98¦~11¤ë19¤é¡]¬P´Á¥|¡^15:30-17:00;¤¤µØ¥Á°êÀç¾i¹«~¨ó·|©ó¥x¥_¥«¶i¥X¤f°Ó·~¦P·~¤½·|¡]¥x¥_¥«ªQ¦¿¸ô350¸¹11¼Ó¡^Á|¿ìÁ¿²ß·|¡C¥DÃD¤@¡G¹«~·~ªÌ§ë«O²£«~³d¥ô«OÀI¡AºtÁ¿ªÌ¡G©ú¥x²£ª««OÀIªÑ¥÷¦³¤½¥q¶À«ØµØ¥ý¥Í¡C¥DÃD¤G¡G«O¨x¯À§÷¡BªÛ³Â¯À¬ÛÃö°T®§¡C³ø¦W¶O¡A¸Ó¨ó·|·|û300¤¸¡A¨ä¥L500¤¸¡C
8. 8¦~11¤ë20¤é¡]¬P´Á¤¡^8:00-12:30¡F¤¤µØ¥Á°ê¾Ç¦WÃľǷ|©ó±iºaµo°òª÷·|°ê»Ú·|ij¤¤¤ßÁ|¿ì¡u¬ü°êÂåÀø«OÀI§ï²¹ï¥þ²y»sÃIJ£·~»P°ê®aÃÄ«~¥«³õ½ÄÀ»¤ÀªR¡v¡A¶O¥Î2500¤¸¡C
9. 98¦~11¤ë20¤é¡]¬P´Á¤¡^13:00-16:30¡FÃĬF³B©e°U¥xùÖ¸ê°T¬ì§Þ©ó°ª¶¯°ê»«¤j¶º©±©]®bÆU¡]°ª¶¯¥«¥Á¥Í¤G¸ô202¸¹2¼Ó¡^Á|¦æ¡yÃÄ«~¬dÅçµn°O¼f¬d§@·~¹q¤l¤ÆÀ³¥Î±À¼s»¡©ú·|¡z¡]°ª¶¯³õ¡^¡A½Ð¤Whttp://www.pharmasoftware.net/c/c.html¶i¦æ½u¤W³ø¦W¡C
10. 98¦~11¤ë20¤é¡]¬P´Á¤¡^8;30-15:00¡FªÀ¹Îªk¤H¥xÆW¥´À»¤£ªkÃĪ«¦æ°ÊÁp·ù©ó¬ü°ÓÀq¨FªFÃļtªÑ¥÷¦³¤½¥q·|ij«Ç¡]¥x¥_¥«´°¤Æ«n¸ô2¬q216¸¹2A«Ç¡^Á|¿ì¡u¥´À»¤£ªkÃĪ«¬ã°Q·|¡v¡]±Äµø°T¤è¦¡¡A¤¤°Ï¡B«n°Ï¦P®ÉÁ|¿ì¡^¡A§K¶O¡AÃĨƤHûÄ~Äò±Ð¨|¾Ç¤À¥Ó½Ð¤¤
11. 98¦~11¤ë23¤é¡]¬P´Á¤@¡^8:30-17:10¡F°]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß°²±iºaµo°òª÷·|°ê»Ú·|ij¤¤¤ß1001«Ç¡]¥x¥_¥«¤¤¤s«n¸ô11¸¹10¼Ó¡^Á|¿ì¡y·sÃĪ«ªk³W¬ì¾Ç¬ã°Q·|-²Îp¦Ò¶q¡z
Regulatory Science Considerations of the New Drug and Medical Devices Applications ¡V from Statistical Perspective¡C§K¶O¡A·q½Ð¤Î¦¤Wºô³ø¦W¡Chttp://cde.org.tw¡C
12. 98¦~11¤ë24¤é¡]¬P´Á¤G¡^8:30-17:30¡F°]¹Îªk¤H´º±dÃľǰòª÷·|©ó±iºaµo°òª÷·|°ê»Ú·|ijÆU¡]¥x¥_¥«¤¤¤s«n¸ô11¸¹11¼Ó¡^Á|¿ì2009·sÃĬãµoµ¦²¤¹ê°È¬ã°Q·|¡C¶O¥Î3,000¤¸¡A
13. 98¦~11¤ë26¡]¬P´Á¥|¡^8:30-12:00¡F¥xÆWÁ{§ÉÃľǷ|©ó¤å¤Æ¤j¾Ç¤j®LÀ]°ê»Ú·|ijÆU¡]¥x¥_¥««Ø°ê«n¸ô2¬q231¸¹B1¡^Á|¿ì¡uÃÄ«~¥ÍÅé¥i¥Î²v/¥ÍÅé¬Ûµ¥©Ê¡]BA/BE¡^¸ÕÅ礧¬ã¨s¡v®y½Í·|¡A§K¶O¡A½Ð¾¨³t©ó11/13«e§¹¦¨³ø¦W
14. 98¦~12¤ë14¤é¡]¬P´Á¤@¡^8:30-17:20¡F°]¹Îªk¤H¤¤µØ¥Á°ê°Ó«~±ø½Xµ¦¶i·|©ó¥x¤jÂå°|°ê»Ú·|ij¤¤¤ß201·|ij«Ç¡]¥x¥_¥«®}¦{¸ô2¸¹2¼Ó¡^Á|¿ì¡y2009ÂåÀøºÞ²z°ê»ÚÁͶÕÀ³¥Î¬ã°Q·|¡z¡iÂåÀø¦w¥þ»PºÞ²z®Ä¯à¤§°òÆ_¡j¡A§K¶O
ÂåÀø¬Fµ¦¬ÛÃö°T®§
1. 98¦~11¤ë18¤é¡]¬P´Á¤T¡^12:00-14:00¡FÂåÀø¬Fµ¦»PÃÄ»ù©eû·|©ó¥»¤½·|Á|¦æ98¦~«×²Ä11¦¸¤u§@·|ij¡C°Q½×ijÃD¡G
¤@¡B¡u2010¦~ÂåÀø¬Fµ¦¦@ÃÑÀç¡v¶i«×³ø§i¨Ã´£½Ð°Q½×¡C
¤lÃD1¡G¦p¦ó¸¨¹ê¡u©ú½TÃÄ»ù¬Fµ¦¡v¡A¤lÃD2¡GÃĶOÁ`ÃB¤ä¥X¥Ø¼Ðªº±Ò°Ê¡A¤lÃD3¡GÃÄ«~¤ä¥I¨î«×¤Î§ï²ªº°t®M¡A¤lÃD4¡G¦h¤¸¤ÆÃÄ»ù½Õ¾ã¤è®×ªºÀË°Q¡C
¤G¡B¥ßªk°|¼f®Ö°·«O¹wºâ®×¡C
2. 98¦~11¤ë24¤é¡]¬P´Á¤G¡^12:00-14:00¡F¤K¤jÃÄ·~¤½¨ó·|²z¨Æªø¤Î¥Nªí©óTPMA·|ij«Ç¶}·|°Q½×¡G1.ÃÄ«~¤ä¥X¥Ø¼Ð¡C2.ÃÄ»ù°ò·Ç×q¡C3.¨ä¥L¡C
ÂåÀø°|©Ò¬ÛÃö°T®§
1. »²¾É·|¦U¯Åºa¥ÁÂå°|99¦Ü100¦~©Ò»Ý±`³ÆÃÄ«~¶°¤¤±ÄÁʮסA¤w©ó11¤ë11¤é¤½§i¡C»â¼Ð¤Î§ë¼Ð´Á¡G§Y¤é°_¦Ü98¦~12¤ë7¤é8:30¡C¶}»ù®æ¼Ð¤é´Á¡G98¦~12¤ë23-25¤é¡C
2. »²¾É·|¦U¯Åºa¥ÁÂå°|99¦Ü100¦~©Ò»Ý±`³ÆÃÄ«~¶°¤¤±ÄÁÊ¡]®×¸¹98-1302¡^¦X®æ¼tµP¦W³æ¤w¤½§i©ó»²¾É·|ºô¯¸¡A·|û¼t°Ó¦p¹ï¤½§i«~¶µ³W®æ¦³ºÃ°ÝªÌ¡A°È¥²©ó11¤ë16¤é¡]¬P´Á¤@¡^«e¡A¥H´£¥X®Ñ±¸ê®Æ¦V»²¾É·|½Ð¨D§ó¥¿¡C
3. 98¦~11¤ë16¤é¡]¬P´Á¤@¡^13:00-17:30¡FÂåÀø°|©Òµo®i©eû·|©ó¥»¤½·|Á|¦æ98¦~«×²Ä12¦¸¤u§@·|ij¡C°Q½×11¤ë20¤éÁ|¿ì¤§CAPAµ¦²¤¦@ÃÑÀç¡u©Û¼Ð²Õ¡v¤§¬ÛÃöijÃD¡C
·|°È¬ÛÃö°T®§
1. 98¦~11¤ë9¤é¡]¬P´Á¤@¡^12:00-14:00¡F¥»¤½·|²Ä¥|©¡²Ä12¦¸±`°È²zºÊ¨Æ·|´£«eÁ|¦æ¡]ìq11¤ë13¤é¡^¡A°Q½×¡uÃĶOÁ`ÃB¡v¤Î¥»¤½·|¡uµ¦²¤¦@ÃÑÀç¡v¤§Äw¹º¡C
2. 98¦~11¤ë20¤é¡]¬P´Á¤¡^9:00-18:00¡F¥»¤½·|±N©ó¼C¼æ®ü¥~«C¦~¬¡°Ê¤¤¤ß¡]¥x¥_¥«¤¤¤s¥_¸ô¥|¬q16¸¹¡^Á|¿ì¡uCAPAµ¦²¤¦@ÃÑÀç¡v¡C²Ä6¦¸ÃÄ»ù½Õ°¤§«á¡AÃÄ·~¸gÀç³´¤J¦M¾÷¡A¦b¦¹ÃÄ·~¦M«æ¦s¤`¤§®É¡A¯S§OÁ|¿ì¦¹¬ã°Q·|¡A¥H¾®»E¦@ÃÑ¡Aµ¦¹º¤½·|¥¼¨Óªº¤è¦V¡C¦@ÃÑÀç©ÒÀòP¤§Á`µ²»P¦@ÃÑ¡A±N©ó12¤ë3¤é·|û¥Nªí¤j·|¤¤³ø§i¡A¸g¼x¸ßÀò±o¥þÅé·|û¤§¦P·N«á¡A°µ¬°¥»¤½·|¤§¬Fµ¦¤Î¦æ°Êºõ»â¡C
3. 98¦~11¤ë27¤é¡]¬P´Á¤¡^11:00-12:00¡F©ó¼y®õ¶º©±¬À·äÆU¡]¥x¥_¥«ªQ¦¿¸ô186¸¹B1¡^Á|¦æ²Ä¥|©¡²Ä13¦¸±`°È²zºÊ¨Æ·|ij¡C
4. 98¦~11¤ë27¤é¡]¬P´Á¤¡^13:00-15:00¡F©ó¼y®õ¶º©±¬À·äÆU¡]¥x¥_¥«ªQ¦¿¸ô186¸¹B1¡^Á|¦æ²Ä¥|©¡²Ä5¦¸²zºÊ¨ÆÁp®u·|ij¡C
5. 98¦~12¤ë3¤é¡]¬P´Á¥|¡^13:00-17:30¡F¥»¤½·|±N©ó¼C¼æ®ü¥~«C¦~¬¡°Ê¤¤¤ß¡]¥x¥_¥«¤¤¤s¥_¸ô4¬q16¸¹318¶¥±è±Ð«Ç¡^¥l¶}²Ä¥|©¡²Ä¤G¦¸·|û¥Nªí¤j·|¡C
¡i°T®§Âા¡j
¦æ¬F°|½Ã¥Í¸p
98.11.5½Ã¸pÃĦr²Ä0980363836¸¹ ®Ñ¨ç ¥»¤½·|¦¬¤å551¸¹¡]11¤ë¡^
©MÁpÃÄ·~ªÑ¥÷¦³¤½¥qÃĪ«¡u½Ã¸pÃÄ¿é¦r²Ä025090¸¹±oºü¦w½¤¦ç¿õ10²@§J¡]Lepax Film-Coated Tablets 10mg¡^¡yEscitalopram oxalate¡z¡v¦C¤JÃĪ«¦w¥þºÊµø¡A¨äºÊµø´Á¶¡¦Ü100¦~4¤ë13¤é¤î¡C
98.11.9½Ã¸pÃĦr²Ä0980343086¸¹ ¨ç ¥»¤½·|¦¬¤å556¸¹¡]11¤ë¡^
¥D¦®¡G¥»¸p«¥Ó°õ¦æÃÄ«~Á{§É¸ÕÅç¡A½Ð½T¹ê¨Ì¥»¸p94¦~1¤ë6¤é½Ã¸pÃĦr²Ä0930338510¸¹¤½§i¤§¡uÃÄ«~Àu¨}Á{§É¸ÕÅç·Ç«h¡v¿ì²z¡A½Ð¬d·Ó¡C
»¡©ú¡G¬°«O»Ù¨ü¸ÕªÌÅv¯q¨Ã´£¤ÉÁ{§É¸ÕÅç«~½è¡A½Ð¦U¸ÕÅ礤¤ß¿í¦u¹ï©óÃÄ«~ºÞ²z¤Î¤Àµo§@·~À³¥ÑÃÄ®v°õ¦æ¡C
98.11.9½Ã¸pÃĦr²Ä0980363866¸¹ ®Ñ¨ç ¥»¤½·|¦¬¤å559¸¹¡]11¤ë¡^
¥D¦®¡G×¥¿¥»¸p98¦~9¤ë30¤é½Ã¸pÃĦr²Ä0980363150¸¹¨ç¦³Ãö§tDeferasirox¦¨¤ÀÃÄ«~¤§ÃÄ«~¦w¥þ¸ê°T¦p»¡©ú¬q¡A½Ð ¬d·Ó¡C
¡° ¥þ¨ç¤U¸ü¡C
98.11.10½Ã¸pÃĦr²Ä0980363888¸¹ ®Ñ¨ç ¥»¤½·|¦¬¤å560¸¹¡]11¤ë¡^
¥D¦®¡GÀË°eÃÄ«~¡u½Ã¸pµß¬Ì¿é¦r²Ä000837¸¹¥ñ±a¯l ¬¡©Ê±aª¬疱¯l¬Ì]¡]ZOSTAVAX¡ezoster virus vaccine live¡]Oka/Merck¡^,MSD¡f¡^¡y¡]PLAQUE-FORMING UNITS¡^OF OKA/MERCK STRAIN OF VZV¡z¡v¤§Á{§É¸ÕÅçpµeºKn1¥÷¡A½Ð ¬d¦¬¡C
¡° ¥þ¨ç¤ÎÁ{§É¸ÕÅçpµeºKn¤U¸ü¡C
98.11.10½Ã¸pÃĦr²Ä0980363887¸¹ ®Ñ¨ç ¥»¤½·|¦¬¤å561¸¹¡]11¤ë¡^
¬ü°ÓÀq¨FªFÃļtªÑ¥÷¦³¤½¥q¥xÆW¤À¤½¥qÃÄ«~¡u½Ã¸pµß¬Ì¿é¦r²Ä000837¸¹ ¥ñ±a¯l ¬¡©Ê±aª¬疱¯l¬Ì]¡]ZOSTAVAX¡ezoster virus vaccine live¡]Oka/Merck¡^,MSD¡f¡^¡y¡]PLAQUE-FORMING UNITS¡^OF OKA/MERCK STRAIN OF VZV¡z¡v¦C¤JÃĪ«¦w¥þºÊµø¡A¨äºÊµø´Á¶¡¦Ü102¦~12¤ë15¤é¤î¡C
98.11.5°·«O¼f¦r²Ä0980042969¸¹ ¥O ¥»¤½·|¦¬¤å550¸¹¡]11¤ë¡^
×¥¿¡u¥þ¥Á°·±d«OÀIÃÄ«~µ¹¥I³W©w¡X²Ä2³¹ ¤ßŦ¦åºÞ¤ÎµÇŦÃĪ« Cardiovascular-renal drugs 2.8.2. ªÍ°Ê¯ß°ª¦åÀ£ªvÀø¾¯¡vµ¹¥I³W©w¡A¨Ã¦Û¤¤µØ¥Á°ê¤E¤Q¤K¦~¤Q¤G¤ë¤@¤é¥Í®Ä¡C
¡° ×¥¿µ¹¥I³W©w½Ð¤U¸ü¡C
98.11.10°·«O¼f¦r²Ä0980095700¸¹ ¥O ¥»¤½·|¦¬¤å558¸¹¡]11¤ë¡^
×¥¿¡u¥þ¥Á°·±d«OÀIÃÄ«~µ¹¥I³W©w¡X²Ä3³¹ ¥NÁ¤ÎÀç¾i¾¯Metabolic ¡® nutrient agents 3.1.1.fat emulsion©Î§tFat emulsion¤§ÀR¯ßÀç¾i¿é²G¡]¦p§tglucose¡Blipid¡B amino acid¤Îelectrolytes¤T¦X¤@ÀR¯ßÀç¾i¿é²G¡^¡v³¡¤À³W©w¡A¨Ã¦Û¤¤µØ¥Á°ê98¦~12¤ë1¤é¥Í®Ä¡C
98.11.5¥þ°Ó·|¦r²Ä0980000463¸¹ ¨ç ¥»¤½·|¦¬¤å552¸¹¡]11¤ë¡^
¥D¦®¡G¡u¤u°Ó¹ÎÅé·|°È¤u§@¤HûºÞ²z¿ìªk¡v¡A·~¸g¤º¬F³¡©ó98¦~11¤ë2¤é¥H¤º±Â¤¤ªÀ¦r²Ä0980703905¸¹¥O×¥¿µo¥¬¡A½Ð¦Ü¦æ¬F°|¤½³ø¸ê°Tºô¤U¸ü¡]ºô§}http://gazette.nat.gov.tw¡^©Î¤W¥»·|ºô¯¸¦Ü¡u°T®§¤½§i¡v¤U¸ü¡A½Ð¬d·Ó¨ÃÂા©ÒÄÝ¡C
¡°×¥¿«á¤§¡u¤u°Ó¹ÎÅé·|°È¤u§@¤HûºÞ²z¿ìªk¡v¤U¸ü¡C |